Mar­ket­ingRx roundup: Pfiz­er boosts RSV vac­cine Abrys­vo cam­paign; J&J videos spot­light re­named Janssen unit

Last year
Pharma
Marketing

J&J, Gen­mab re­veal first-line da­ta for Darza­lex Faspro, plus new man­tle cell lym­phoma re­sults for ...

Last year
R&D
Pharma

Al­to Neu­ro­science clos­es $45M round; Sim­cere part­ners with Con­nect; Myricx li­cens­es WuXi an­ti­body

Last year
News Briefing

Nvidia signs deal with Genen­tech to pair drug­mak­er's ma­chine learn­ing with chip sup­pli­er's tech

Last year
Deals
AI

Up­dat­ed: Mer­ck com­mits up to $610M to buy out pre­clin­i­cal biotech and its neu­rode­gen­er­a­tive dis­ease work

Last year
Deals

BeiGene li­cens­es CDK2 in­hibitor from En­sem in po­ten­tial $1.33B deal

Last year
Deals

GSK boosts low-car­bon in­haler de­vel­op­ment with PhI­II tri­als, in­vest­ment in French man­u­fac­tur­ing fa­cil­i­ty 

Last year
Pharma
Manufacturing

Mor­phoSys march­es ahead with plans to file myelofi­bro­sis drug de­spite mixed PhI­II re­sults

Last year
R&D

Flag­ship launch­es first UK-based start­up to un­cov­er genes that make cells vul­ner­a­ble or re­sis­tant to dis­ease

Last year
Financing
Startups

For­mer col­lege room­mates com­bine health and tech back­grounds to raise $58M for new fund

Last year
Financing
Health Tech

As­cendis Phar­ma's hy­poparathy­roidism drug scores Eu­ro­pean ap­proval af­ter re­fil­ing in the US

Last year
Pharma
FDA+

Phar­ma com­pa­nies qui­et about ad plans on X amid de­par­ture of ma­jor con­sumer brands

Last year
Pharma
Marketing

New FDA rule for phar­ma ad­ver­tise­ments re­quires side ef­fects to be ex­plained clear­ly

Last year
FDA+
Marketing

Sen­ate De­moc­rats press As­traZeneca, Sanofi on RSV an­ti­body short­age

Last year
Pharma
FDA+

CAR-T cell ther­a­pies in­fused in­to brain shrink tu­mors in two glioblas­toma stud­ies

Last year
R&D
Cell/Gene Tx

Bris­tol My­ers and 2sev­en­ty bio say FDA de­layed CAR-T ther­a­py de­ci­sion

Last year
Cell/Gene Tx
FDA+

Chiesi’s new li­cens­ing deal with Hais­co; Ox­u­ri­on to file for bank­rupt­cy; Hong Kong CD­MO rais­es $210M

Last year
News Briefing

'Faster to­geth­er': As­traZeneca breaks in­to clin­i­cal ser­vices busi­ness with new com­pa­ny launch, lin­ing up two CRO ...

Last year
Health Tech

'In­fe­ri­or ef­fi­ca­cy' leads to pre­ma­ture end of PhI­II for Bay­er's next-gen blood thin­ner asun­dex­i­an

Last year
R&D

Bay­er re­calls one lot of sol­id tu­mor drug Vi­t­rakvi af­ter find­ing mi­cro­bial con­t­a­m­i­na­tion

Last year
Pharma
Manufacturing

UK phar­ma in­dus­try signs land­mark deal with gov­ern­ment health ser­vice over drug prices

Last year
Pharma

Land­mark CRISPR ap­proval; Why don't in­vestors like Verve’s base edit­ing da­ta?; Janet Wood­cock to re­tire; Late ...

Last year
Weekly

Obe­si­ty and di­a­betes biotech Car­mot Ther­a­peu­tics files for IPO

Last year
Financing
Startups

Mer­ck cough drug fails to win ad­comm’s back­ing as FDA rais­es ef­fi­ca­cy ques­tions

Last year
R&D
First page Previous page 242243244245246247248 Next page Last page
A service from the Financial Times